Takashi Nishimura

16.4k total citations · 1 hit paper
448 papers, 9.2k citations indexed

About

Takashi Nishimura is a scholar working on Immunology, Surgery and Oncology. According to data from OpenAlex, Takashi Nishimura has authored 448 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Immunology, 103 papers in Surgery and 94 papers in Oncology. Recurrent topics in Takashi Nishimura's work include Immune Cell Function and Interaction (95 papers), Mechanical Circulatory Support Devices (75 papers) and Immunotherapy and Immune Responses (74 papers). Takashi Nishimura is often cited by papers focused on Immune Cell Function and Interaction (95 papers), Mechanical Circulatory Support Devices (75 papers) and Immunotherapy and Immune Responses (74 papers). Takashi Nishimura collaborates with scholars based in Japan, United States and Thailand. Takashi Nishimura's co-authors include Hidemitsu Kitamura, Daiko Wakita, Kenji Chamoto, Hiroko Iijima, Takayuki Ohkuri, Akio Ohta, Yuji Togashi, Hirayuki Enomoto, Takashi Yahata and Marimo Sato and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Takashi Nishimura

433 papers receiving 9.0k citations

Hit Papers

The Natural Killer T (NKT) Cell Ligand α-Galactosylcerami... 1999 2026 2008 2017 1999 100 200 300 400 500

Peers

Takashi Nishimura
C. Wayne Smith United States
Petra Reinke Germany
Johann Wojta Austria
C. Erik Hack Netherlands
Florian Rieder United States
C. Wayne Smith United States
Takashi Nishimura
Citations per year, relative to Takashi Nishimura Takashi Nishimura (= 1×) peers C. Wayne Smith

Countries citing papers authored by Takashi Nishimura

Since Specialization
Citations

This map shows the geographic impact of Takashi Nishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Nishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Nishimura more than expected).

Fields of papers citing papers by Takashi Nishimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashi Nishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Nishimura. The network helps show where Takashi Nishimura may publish in the future.

Co-authorship network of co-authors of Takashi Nishimura

This figure shows the co-authorship network connecting the top 25 collaborators of Takashi Nishimura. A scholar is included among the top collaborators of Takashi Nishimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takashi Nishimura. Takashi Nishimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Komatsu, Shohei, Toshifumi Tada, Takashi Nishimura, et al.. (2025). Prognosis of Hepatectomy versus Systemic Chemotherapy Based on Oncological Resectability Criteria for Borderline Resectable Hepatocellular Carcinoma. Liver Cancer. 15(1). 38–49. 1 indexed citations
3.
Matono, Tomomitsu, Toshifumi Tada, Takashi Nishimura, et al.. (2023). VFMAP predicted hepatocellular carcinoma development in patients with chronic hepatitis C who were treated with direct-acting antiviral and achieved sustained virologic response. Journal of Medical Ultrasonics. 51(2). 293–300. 1 indexed citations
4.
Enomoto, Hirayuki, Yukihisa Yuri, Takashi Nishimura, et al.. (2023). A Low Geriatric Nutritional Risk Index Is Associated with Low Muscle Volume and a Poor Prognosis among Cirrhotic Patients. Medicina. 59(12). 2099–2099.
5.
Enomoto, Hirayuki, et al.. (2023). Determination of the Possible Target Genes of Hepatoma-derived Growth Factor in Hepatoma Cells. In Vivo. 37(5). 1975–1979. 2 indexed citations
7.
Ito, Akihiro, Isao Ito, Satoshi Marumo, et al.. (2020). The utility of serial procalcitonin measurements in addition to pneumonia severity scores in hospitalised community-acquired pneumonia: A multicentre, prospective study. International Journal of Infectious Diseases. 92. 228–233. 13 indexed citations
8.
Nishimura, Takashi, Makoto Mitsunaga, Kimihiro Ito, Hisataka Kobayashi, & Masayuki Saruta. (2019). Cancer neovasculature-targeted near-infrared photoimmunotherapy (NIR-PIT) for gastric cancer: different mechanisms of phototoxicity compared to cell membrane-targeted NIR-PIT. Gastric Cancer. 23(1). 82–94. 26 indexed citations
9.
Yoh, Kazunori, Hiroki Nishikawa, Hirayuki Enomoto, et al.. (2018). Effect of exercise therapy on sarcopenia in pancreatic cancer: a study protocol for a randomised controlled trial. BMJ Open Gastroenterology. 5(1). e000194–e000194. 10 indexed citations
10.
Ito, Kimihiro, Makoto Mitsunaga, Takashi Nishimura, et al.. (2017). Near-Infrared Photochemoimmunotherapy by Photoactivatable Bifunctional Antibody–Drug Conjugates Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancer. Bioconjugate Chemistry. 28(5). 1458–1469. 30 indexed citations
11.
Tada, Kohei, Shigehisa Kitano, Hirokazu Shoji, et al.. (2016). Pretreatment Immune Status Correlates with Progression-Free Survival in Chemotherapy-Treated Metastatic Colorectal Cancer Patients. Cancer Immunology Research. 4(7). 592–599. 54 indexed citations
12.
Takashima, Tomoyuki, Hirayuki Enomoto, Yoshinori Iwata, et al.. (2016). Effects of Helicobacter pylori Eradication on the Platelet Count in Hepatitis C Virus-Infected Patients. Journal of Clinical Medicine Research. 8(12). 854–858. 5 indexed citations
13.
Kitajima, Masayuki, Toshihiro Ito, Damon J. Tumes, et al.. (2011). Memory Type 2 Helper T Cells Induce Long-Lasting Antitumor Immunity by Activating Natural Killer Cells. Cancer Research. 71(14). 4790–4798. 24 indexed citations
14.
Takeshima, Tsuguhide, Kenji Chamoto, Daiko Wakita, et al.. (2010). Local Radiation Therapy Inhibits Tumor Growth through the Generation of Tumor-Specific CTL: Its Potentiation by Combination with Th1 Cell Therapy. Cancer Research. 70(7). 2697–2706. 201 indexed citations
15.
Usagawa, Tsuyoshi, et al.. (2003). An Active Control System of Ambulance Siren by means of Loudspeakers Mounted in Headset. 한국소음진동공학회 국제학술발표논문집. 1020–1025. 1 indexed citations
16.
Sato, Marimo, Kenji Chamoto, Takemasa Tsuji, et al.. (2001). Th1 Cytokine-Conditioned Bone Marrow-Derived Dendritic Cells Can Bypass the Requirement for Th Functions During the Generation of CD8+ CTL. The Journal of Immunology. 167(7). 3687–3691. 13 indexed citations
17.
Takaoka, Akiko, Yoshitaka Tanaka, Takemasa Tsuji, et al.. (2001). A Critical Role for Mouse CXC Chemokine(s) in Pulmonary Neutrophilia During Th Type 1-Dependent Airway Inflammation. The Journal of Immunology. 167(4). 2349–2353. 54 indexed citations
18.
Ohta, Akio, Masashi Sekimoto, Marimo Sato, et al.. (2000). Indispensable Role for TNF-α and IFN-γ at the Effector Phase of Liver Injury Mediated by Th1 Cells Specific to Hepatitis B Virus Surface Antigen. The Journal of Immunology. 165(2). 956–961. 59 indexed citations
19.
Nishimura, Takashi. (1998). The Important Role of TH1/TH2 Balance in Immune Disease : its Regulation by Interleukin-12. 23(6). 345. 1 indexed citations
20.
Shimizu, M., et al.. (1997). Establishment of a Standardized Assay System of Fibronectin Activity Using Fibronectin-Mediated Cell Adhesion.. Biological and Pharmaceutical Bulletin. 20(12). 1219–1223. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026